MEI Pharma in at-the-Market Equity Offering for up to $30M By Kimberly Yuen (Bloomberg) -- MEI Pharma in at-the-market equity offering sales agreement with Stifel, Nicolaus for up to $30m of shares. MEIP scheduled to report 2Q earnings on Nov. 8 NOTE: MEI Pharma’s Pracinostat Got EU Orphan Designation